Skip to main content

Table 2 Overview of different variables in Pimobendan- and placebo-group

From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

Variable

Pimobendan

Placebo

Number

10

10

Gender (M/F)

7/3

3/7

Age (years, mean ± SD)

10.3 ± 2.8

8 ± 2.8

Weight (kg, mean ± SD)

14 ± 7.7

17.3 ± 8.7

Murmur (I/II/III/IV)

5/2/0/3

5/4/0/1

Speed (km/h, mean ± SD)

5.5 ± 1.3

5.7 ± 1.3

  1. This table shows the number of dogs (n), gender (M/F), age (years; mean ± standard deviation (SD)), weight (kg; mean ± SD), heart murmur (grades I-VI/VI), and the speed running on the treadmill (km/h; mean ± SD) of Pimobendan- and placebo-group. The Pimobendan dose (mg/kg/d; mean ± SD) is also shown
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us